Merck Gets Favorable Opinion From CHMP For Its ZEPATIER
May 27, 2016 at 08:38 AM EDT
Merck & Co., Inc. (NYSE: MRK) disclosed Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.